XM does not provide services to residents of the United States of America.
U
U

UltaBeauty

News

Berkshire invests in Ulta Beauty, Heico as it retreats from Apple

UPDATE 2-Berkshire invests in Ulta Beauty, Heico as it retreats from Apple Adds Heico comment, updated after-hours stock prices, paragraphs 3, 6-7 By Jonathan Stempel Aug 14 (Reuters) - Warren Buffett's Berkshire Hathaway BRKa.N acquired stakes in cosmetics store chain Ulta Beauty ULTA.O and aircraft parts maker Heico HEI.N during the second quarter, when it also nearly halved its huge stake in Apple AAPL.O .
A
B
D
K
S
T
U

Ulta Beauty jumps after Buffett's Berkshire Hathaway reveals stake

BUZZ-Ulta Beauty jumps after Buffett's Berkshire Hathaway reveals stake ** Shares of Ulta Beauty ULTA.O up ~12% at $369.50 after the bell ** Warren Buffett's Berkshire Hathaway BRKa.N acquires stake in ULTA ** Berkshire says owns about 690,000 Ulta Beauty shares worth $266.3 mln ** Up to last close, stock was down nearly 33% YTD Reporting by Anuja
U

Berkshire reveals stakes in Ulta Beauty, Heico as it retreats from Apple

Berkshire reveals stakes in Ulta Beauty, Heico as it retreats from Apple Aug 14 (Reuters) - Warren Buffett's Berkshire Hathaway BRKa.N acquired stakes in cosmetics store chain Ulta Beauty ULTA.O and aircraft parts maker Heico HEI.N during the second quarter, when it also significantly cut its huge stake in Apple AAPL.O . Berkshire owned about 690,000 Ulta Beauty shares worth $266.3 million and 1.04 million Heico shares worth $185.4 million as of June 30, according to a Wednesday regulatory filin
A
U

US luxury firms fall after Burberry warns of operating loss in first half of 2024

BUZZ-US luxury firms fall after Burberry warns of operating loss in first half of 2024 ** Shares of U.S. luxury companies fall in afternoon trading after British luxury group Burberry BRBY.L expects to post operating loss for 1H24 ** BRBY also to miss annual profit forecasts prompting it to suspend dividend payments ** Company sacks its CEO and nam
B
U
E
P

U.S. Armada Hoffler Properties, Morphic Holding, Solid Biosciences

U.S. RESEARCH ROUNDUP-Armada Hoffler Properties, Morphic Holding, Solid Biosciences July 15 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Armada Hoffler Properties, Morphic Holding and Solid Biosciences, on Monday. HIGHLIGHTS * Armada Hoffler Properties Inc AHH.N : Jefferies cuts to hold from buy * Morphic Holding Inc MORF.O : Jefferies cuts to hold from buy * Solid Biosciences Inc SLDB.O : JP Morgan raises to over
A
A
C
C
H
J
A
E
P
U
W
A
E
H
M

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.